ANEBULO PHARMACEUTICALS, INC. Interest Income (Expense), after Provision for Loan Loss
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Interest Income (Expense), after Provision for Loan Loss of $36.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseAfterProvisionForLoanLoss · last filed 2025-05-13
- ANEBULO PHARMACEUTICALS, INC. interest income (expense), after provision for loan loss for the quarter ending 2025-03-31 was $36.00K, a 64.00% decline year-over-year.
- ANEBULO PHARMACEUTICALS, INC. interest income (expense), after provision for loan loss for the quarter ending 2024-12-31 was $100.00K, a 99.69% decline year-over-year.
- ANEBULO PHARMACEUTICALS, INC. interest income (expense), after provision for loan loss for the quarter ending 2024-09-30 was $100.00K.
- ANEBULO PHARMACEUTICALS, INC. interest income (expense), after provision for loan loss for the quarter ending 2024-03-31 was $100.00K.
| Period end | Interest Income (Expense), after Provision for Loan Loss 3 month | Interest Income (Expense), after Provision for Loan Loss 6 month | Interest Income (Expense), after Provision for Loan Loss 9 month |
|---|---|---|---|
| 2025-03-31 | $36.00K 10-Q · filed 2025-05-13 | $136.00K derived: sum of 2 quarters · filed 2025-05-13 | $200.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $100.00K 10-Q · filed 2025-02-14 | $100.00K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-13 | ||
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-15 | $32.10M derived: sum of 2 quarters · filed 2025-02-14 | $100.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $32.00M 10-Q · filed 2025-02-14 | $32.00M 10-Q · filed 2025-02-14 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |